speb/financial-data huggingface dataset:
ACU.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -3020.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 583093.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -81767.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 3523178.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 367611.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 367611.00
ACU.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -585098.00
ACU.V income_statement (quarterly, 2024-12-31) — Normalized Income: -731048.09
ACU.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 12618.00
ACU.V income_statement (quarterly, 2024-12-31) — Operating Income: -787496.00
ACU.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 1416501.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 7247.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 451426.00
ACU.V income_statement (quarterly, 2024-12-31) — Other Gand A: 210409.00
ACU.V income_statement (quarterly, 2024-12-31) — Other Income Expense: -427143.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 656766.00
ACU.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 663196.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 68842.00
ACU.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 180.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 657708.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 922998.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 251615.00
ACU.V income_statement (quarterly, 2024-12-31) — Pretax Income: -1217659.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
ACU.V cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -27.00
ACU.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -81767.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Raw Materials: 2752285.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Receivables: 442958.00
ACU.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 683360.00
ACU.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 202218.00
ACU.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -37984.00
ACU.V income_statement (quarterly, 2024-12-31) — Research And Development: 207647.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -27401583.00
ACU.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 747817.00
ACU.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 152546.00
ACU.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1110772.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 222194076.00
ACU.V cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
ACU.V income_statement (quarterly, 2024-12-31) — Special Income Charges: -628927.00
ACU.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 51644.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 4179944.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 3523178.00
ACU.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -32056.09
ACU.V income_statement (quarterly, 2024-12-31) — Tax Provision: -91344.00
ACU.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.08
ACU.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 43701.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 7450257.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 4206572.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 221422.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 4179944.00
ACU.V income_statement (quarterly, 2024-12-31) — Total Expenses: 2203997.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 3270313.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 1676312.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 152196.00
ACU.V income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -1214819.00
ACU.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: -427323.00
ACU.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -427323.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Work In Process: 839351.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 2655828.00
ACU.V income_statement (quarterly, 2024-12-31) — Write Off: 0.00
ACU.V income_statement (annual, 2025-03-31) — +Operating Expense: 5505249.00
ACU.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 679016.00
ACU.V income_statement (annual, 2025-03-31) — +Total Revenue: 6293909.00
ACU.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 794710.00
ACU.V balance_sheet (annual, 2025-03-31) — Accounts Receivable: 158966.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 158966.00
ACU.V balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -791280.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -791280.00
ACU.V balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 3435203.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3435203.00
ACU.V cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 1228465.00
ACU.V cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 599538.00
ACU.V income_statement (annual, 2025-03-31) — Basic Average Shares: 222194076.00
ACU.V income_statement (annual, 2025-03-31) — Basic EPS: -0.01
ACU.V cash_flow (annual, 2025-03-31) — Beginning Cash Position: 2850338.00
ACU.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1169977.00
ACU.V balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 509709.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 509709.00
ACU.V cash_flow (annual, 2025-03-31) — Capital Expenditure: -374291.00
ACU.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -57129.00
ACU.V balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 92361.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 92361.00
ACU.V balance_sheet (annual, 2025-03-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1257957.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1257957.00
ACU.V balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1257957.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1257957.00
ACU.V cash_flow (annual, 2025-03-31) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Cash Financial: 1257957.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1257957.00
ACU.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 444587.00
ACU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 603044.00
ACU.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -382547.00
ACU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -57129.00
ACU.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1694810.00
ACU.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -349870.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Account Payable: 177384.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Income Tax Payable: 0.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Inventory: -237329.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: 37327.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Other Working Capital: -934392.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -300934.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Payable: 177384.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 177384.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 612499.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: 529315.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 162070.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Receivables: -324369.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -875381.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Tax Payable: 0.00
ACU.V cash_flow (annual, 2025-03-31) — Change In Working Capital: -789391.00
ACU.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -364419.00
ACU.V cash_flow (annual, 2025-03-31) — Changes In Cash: -1632770.00
ACU.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 196045.00
ACU.V balance_sheet (annual, 2025-03-31) — Common Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 27706728.00
ACU.V balance_sheet (annual, 2025-03-31) — Common Stock Equity: 2951006.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2951006.00
ACU.V income_statement (annual, 2025-03-31) — Cost Of Revenue: 2692353.00
ACU.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 251869.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Assets: 6335610.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 6335610.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 92361.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 92361.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Debt: 686147.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 686147.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 778508.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 778508.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 1733724.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1733724.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 1733724.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1733724.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Liabilities: 4024822.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4024822.00
ACU.V balance_sheet (annual, 2025-03-31) — Current Provisions: 62681.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Current Provisions: 62681.00
ACU.V cash_flow (annual, 2025-03-31) — Deferred Income Tax: 163955.00
ACU.V cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 489985.00
ACU.V cash_flow (annual, 2025-03-31) — Deferred Tax: 163955.00
ACU.V cash_flow (quarterly, 2025-03-31) — Deferred Tax: 489985.00
ACU.V cash_flow (annual, 2025-03-31) — Depreciation: 677933.00
ACU.V cash_flow (quarterly, 2025-03-31) — Depreciation: 155686.00
ACU.V cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 677933.00
ACU.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 155686.00
ACU.V income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 677933.00
ACU.V income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 155686.00
ACU.V cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 677933.00
ACU.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 155686.00
ACU.V income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 677933.00
ACU.V income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 155686.00
ACU.V income_statement (annual, 2025-03-31) — Depreciation Income Statement: 677933.00
ACU.V income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 155686.00
ACU.V income_statement (annual, 2025-03-31) — Diluted Average Shares: 222194076.00
ACU.V income_statement (annual, 2025-03-31) — Diluted EPS: -0.01
ACU.V income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — EBIT: -3250795.00
ACU.V income_statement (quarterly, 2025-03-31) — EBIT: -947650.00
ACU.V income_statement (annual, 2025-03-31) — EBITDA: -2572862.00
ACU.V income_statement (quarterly, 2025-03-31) — EBITDA: -791964.00
ACU.V cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 40389.00
ACU.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -108065.00
ACU.V cash_flow (annual, 2025-03-31) — End Cash Position: 1257957.00
ACU.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 1257957.00
ACU.V cash_flow (annual, 2025-03-31) — Financing Cash Flow: 444587.00
ACU.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 603044.00
ACU.V balance_sheet (annual, 2025-03-31) — Finished Goods: 463989.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Finished Goods: 463989.00
ACU.V cash_flow (annual, 2025-03-31) — Free Cash Flow: -2069101.00
ACU.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -406999.00
ACU.V cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
ACU.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
ACU.V income_statement (annual, 2025-03-31) — Gain On Sale Of Security: -135844.00
ACU.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -221770.00
ACU.V balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 442079.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 442079.00
ACU.V income_statement (annual, 2025-03-31) — General And Administrative Expense: 4145649.00
ACU.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1002911.00
ACU.V balance_sheet (annual, 2025-03-31) — Goodwill: 0.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 378868.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 378868.00
ACU.V balance_sheet (annual, 2025-03-31) — Gross PPE: 1132265.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1132265.00
ACU.V income_statement (annual, 2025-03-31) — Gross Profit: 3601556.00
ACU.V income_statement (quarterly, 2025-03-31) — Gross Profit: 542841.00
ACU.V income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 1054252.00
ACU.V income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 425325.00
ACU.V income_statement (annual, 2025-03-31) — Interest Expense: 14537.00
ACU.V income_statement (quarterly, 2025-03-31) — Interest Expense: 2854.00
ACU.V income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 14537.00
ACU.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2854.00
ACU.V cash_flow (annual, 2025-03-31) — Interest Paid Cff: -14537.00
ACU.V cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 14537.00
ACU.V balance_sheet (annual, 2025-03-31) — Inventory: 3872067.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Inventory: 3872067.00
ACU.V balance_sheet (annual, 2025-03-31) — Invested Capital: 3661871.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3661871.00
ACU.V cash_flow (annual, 2025-03-31) — Investing Cash Flow: -382547.00
ACU.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -57129.00
ACU.V cash_flow (annual, 2025-03-31) — Issuance Of Debt: 678745.00
ACU.V balance_sheet (annual, 2025-03-31) — Leases: 18200.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Leases: 18200.00
ACU.V balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Long Term Debt: 24718.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 24718.00
ACU.V balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24718.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 24718.00
ACU.V cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 678745.00
ACU.V cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -219621.00
ACU.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -61164.00
ACU.V balance_sheet (annual, 2025-03-31) — Long Term Provisions: 28554.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 28554.00
ACU.V balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 98710.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 98710.00
ACU.V income_statement (annual, 2025-03-31) — Net Income: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1231421.00
ACU.V cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -3220219.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1231421.00
ACU.V income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -3220219.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1231421.00
ACU.V cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -1435.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 10.00
ACU.V income_statement (annual, 2025-03-31) — Net Interest Income: -14537.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -2854.00
ACU.V cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 459124.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 617581.00
ACU.V cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 459124.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 617581.00
ACU.V income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -14537.00
ACU.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2854.00
ACU.V cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -8256.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Net PPE: 340985.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 340985.00
ACU.V cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -372856.00
ACU.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -57139.00
ACU.V balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 2572138.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2572138.00
ACU.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Assets: 0.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 68201.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 68201.00
ACU.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
ACU.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 68201.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 68201.00
ACU.V income_statement (annual, 2025-03-31) — Normalized EBITDA: -1208553.00
ACU.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 29344.00
ACU.V income_statement (annual, 2025-03-31) — Normalized Income: -1874758.95
ACU.V income_statement (quarterly, 2025-03-31) — Normalized Income: -533309.20
ACU.V cash_flow (annual, 2025-03-31) — Operating Cash Flow: -1694810.00
ACU.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -349870.00
ACU.V income_statement (annual, 2025-03-31) — Operating Income: -1903693.00
ACU.V income_statement (quarterly, 2025-03-31) — Operating Income: -136175.00
ACU.V income_statement (annual, 2025-03-31) — Operating Revenue: 6293909.00
ACU.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 794710.00
ACU.V balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 686147.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 686147.00
ACU.V balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 442079.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 442079.00
ACU.V income_statement (annual, 2025-03-31) — Other Gand A: 1086151.00
ACU.V income_statement (quarterly, 2025-03-31) — Other Gand A: 321123.00
ACU.V income_statement (annual, 2025-03-31) — Other Income Expense: -1347102.00
ACU.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -811475.00
ACU.V balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 378868.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 378868.00
ACU.V cash_flow (annual, 2025-03-31) — Other Non Cash Items: 14537.00
ACU.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -11069.00
ACU.V balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 41838.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 41838.00
ACU.V income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 17207.00
ACU.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 9833.00
ACU.V income_statement (annual, 2025-03-31) — Other Operating Expenses: -853162.00
ACU.V balance_sheet (annual, 2025-03-31) — Other Properties: 505646.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 505646.00
ACU.V balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 1449909.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1449909.00
ACU.V balance_sheet (annual, 2025-03-31) — Prepaid Assets: 89545.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 89545.00
ACU.V income_statement (annual, 2025-03-31) — Pretax Income: -3265332.00
ACU.V income_statement (quarterly, 2025-03-31) — Pretax Income: -950504.00
ACU.V balance_sheet (annual, 2025-03-31) — Properties: 0.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ACU.V cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -1435.00
ACU.V cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 10.00
ACU.V cash_flow (annual, 2025-03-31) — Purchase Of PPE: -372856.00
ACU.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -57139.00
ACU.V balance_sheet (annual, 2025-03-31) — Raw Materials: 2471902.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2471902.00
ACU.V balance_sheet (annual, 2025-03-31) — Receivables: 1071091.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Receivables: 1071091.00
ACU.V income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2692353.00
ACU.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 251869.00
ACU.V income_statement (annual, 2025-03-31) — Reconciled Depreciation: 677933.00
ACU.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 155686.00
ACU.V cash_flow (annual, 2025-03-31) — Repayment Of Debt: -219621.00
ACU.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -61164.00
ACU.V income_statement (annual, 2025-03-31) — Research And Development: 867926.00
ACU.V income_statement (quarterly, 2025-03-31) — Research And Development: 186832.00
ACU.V balance_sheet (annual, 2025-03-31) — Restricted Cash: 44950.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 44950.00
ACU.V balance_sheet (annual, 2025-03-31) — Retained Earnings: -28633004.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -28633004.00
ACU.V income_statement (annual, 2025-03-31) — Salaries And Wages: 3059498.00
ACU.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 681788.00
ACU.V cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
ACU.V income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 666903.00
ACU.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 186749.00
ACU.V income_statement (annual, 2025-03-31) — Selling General And Administration: 4812552.00
ACU.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1189660.00
ACU.V balance_sheet (annual, 2025-03-31) — Share Issued: 222194076.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 222194076.00
ACU.V income_statement (annual, 2025-03-31) — Special Income Charges: -1228465.00
ACU.V income_statement (quarterly, 2025-03-31) — Special Income Charges: -599538.00
ACU.V cash_flow (annual, 2025-03-31) — Stock Based Compensation: 229910.00
ACU.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 11830.00
ACU.V balance_sheet (annual, 2025-03-31) — Stockholders Equity: 2951006.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2951006.00
ACU.V balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2572138.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2572138.00
ACU.V income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -18848.95
ACU.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -123196.20
ACU.V income_statement (annual, 2025-03-31) — Tax Provision: -45113.00
ACU.V income_statement (quarterly, 2025-03-31) — Tax Provision: 280917.00
ACU.V income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.01
ACU.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
ACU.V balance_sheet (annual, 2025-03-31) — Taxes Receivable: 912125.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 912125.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Assets: 7097301.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 7097301.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Capitalization: 2975724.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2975724.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Debt: 803226.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 803226.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2951006.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2951006.00
ACU.V income_statement (annual, 2025-03-31) — Total Expenses: 8197602.00
ACU.V income_statement (quarterly, 2025-03-31) — Total Expenses: 930885.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4146295.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4146295.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 761691.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 761691.00
ACU.V balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 121473.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 121473.00
ACU.V income_statement (annual, 2025-03-31) — Total Operating Income As Reported: 4121164.00
ACU.V income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 6431683.00
ACU.V income_statement (annual, 2025-03-31) — Total Unusual Items: -1364309.00
ACU.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -821308.00
ACU.V income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1364309.00
ACU.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -821308.00
ACU.V balance_sheet (annual, 2025-03-31) — Work In Process: 936176.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Work In Process: 936176.00
ACU.V balance_sheet (annual, 2025-03-31) — Working Capital: 2310788.00
ACU.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 2310788.00
ACU.V income_statement (annual, 2025-03-31) — Write Off: 174213.00
ACU.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 1274434.00
ACU.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 551166.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 237811.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -862025.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3464723.00
ACU.V cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: -189126.00
ACU.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
ACU.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1257957.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 537409.00
ACU.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -134524.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 35208.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 250500.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 250500.00
ACU.V cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 250500.00
ACU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -60190.00
ACU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -136861.00
ACU.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1032245.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: 156966.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -231852.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 62370.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -15298.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -90131.00
ACU.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -117945.00
ACU.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1229296.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2318592.00
ACU.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 414565.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 5465457.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 35208.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Debt: 703020.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 738228.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1365178.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1365178.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3778995.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Current Provisions: 198236.00
ACU.V cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
ACU.V cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
ACU.V cash_flow (quarterly, 2025-06-30) — Depreciation: 148003.00
ACU.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 148003.00
ACU.V income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 148003.00
ACU.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 148003.00
ACU.V income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 148003.00
ACU.V income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 148003.00
ACU.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
ACU.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — EBIT: -879786.00
ACU.V income_statement (quarterly, 2025-06-30) — EBITDA: -731783.00
ACU.V cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 221839.00
ACU.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 250500.00
ACU.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -60190.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Finished Goods: 219539.00
ACU.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1166769.00
ACU.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
ACU.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 15730.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 684087.00
ACU.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 849562.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 354519.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1215122.00
ACU.V income_statement (quarterly, 2025-06-30) — Gross Profit: 136601.00
ACU.V income_statement (quarterly, 2025-06-30) — Interest Expense: 1245.00
ACU.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1245.00
ACU.V cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -1245.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Inventory: 3715101.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3044380.00
ACU.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -136861.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Leases: 18180.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 22768.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 22768.00
ACU.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -58945.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 29891.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 98601.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 475288.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -903942.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -903942.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -903942.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -1245.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -58945.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -58945.00
ACU.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1245.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -2337.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 353097.00
ACU.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -134524.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1964073.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 68201.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 68201.00
ACU.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -936639.00
ACU.V income_statement (quarterly, 2025-06-30) — Normalized Income: -1078069.60
ACU.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1032245.00
ACU.V income_statement (quarterly, 2025-06-30) — Operating Income: -1137833.00
ACU.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 551166.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 703020.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 684087.00
ACU.V income_statement (quarterly, 2025-06-30) — Other Gand A: 186956.00
ACU.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 258047.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 354519.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Inventories: 1.00
ACU.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1245.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 44175.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: -1199.00
ACU.V income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 53191.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 560932.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1477353.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 104843.00
ACU.V income_statement (quarterly, 2025-06-30) — Pretax Income: -881031.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ACU.V cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: 0.00
ACU.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -134524.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Raw Materials: 2458130.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Receivables: 1350348.00
ACU.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 414565.00
ACU.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 148003.00
ACU.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -58945.00
ACU.V income_statement (quarterly, 2025-06-30) — Research And Development: 182630.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 44665.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -29536946.00
ACU.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 662606.00
ACU.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 94239.00
ACU.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 943801.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 222194076.00
ACU.V income_statement (quarterly, 2025-06-30) — Special Income Charges: 189126.00
ACU.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 29520.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2318592.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1964073.00
ACU.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 30728.40
ACU.V income_statement (quarterly, 2025-06-30) — Tax Provision: 22911.00
ACU.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
ACU.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 1112537.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 6217248.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 2341360.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 760996.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2318592.00
ACU.V income_statement (quarterly, 2025-06-30) — Total Expenses: 1688999.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3898656.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 751791.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 119661.00
ACU.V income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -932977.00
ACU.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: 204856.00
ACU.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 204856.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Work In Process: 1037431.00
ACU.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 1686462.00
ACU.V income_statement (quarterly, 2025-06-30) — Write Off: -189126.00
ACU.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 1127264.00
ACU.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 991581.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 274048.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -879390.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3488481.00
ACU.V cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -1593.00
ACU.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
ACU.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 250500.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 1014195.00
ACU.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -20574.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 490174.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 613189.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 613189.00
ACU.V cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 613189.00
ACU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -767763.00
ACU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -20574.00
ACU.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1004746.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Inventory: -13054.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 140404.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 295509.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -62333.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: 856907.00
ACU.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1217433.00
ACU.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 856907.00
ACU.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: 216409.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2107486.00
ACU.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 343893.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 5049328.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 245087.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 7722.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 252809.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1486184.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1486184.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3761334.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Current Provisions: 214551.00
ACU.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
ACU.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
ACU.V cash_flow (quarterly, 2025-09-30) — Depreciation: 95913.00
ACU.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 95913.00
ACU.V income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 95913.00
ACU.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 95913.00
ACU.V income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 95913.00
ACU.V income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 95913.00
ACU.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
ACU.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — EBIT: -271589.00
ACU.V income_statement (quarterly, 2025-09-30) — EBITDA: -175676.00
ACU.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 146280.00
ACU.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 613189.00
ACU.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -767763.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Finished Goods: 106185.00
ACU.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 984172.00
ACU.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
ACU.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 7970.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 780973.00
ACU.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 820557.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 333147.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1688401.00
ACU.V income_statement (quarterly, 2025-09-30) — Gross Profit: 647688.00
ACU.V income_statement (quarterly, 2025-09-30) — Interest Expense: 30658.00
ACU.V income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 30658.00
ACU.V cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -28427.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Inventory: 3728155.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2147984.00
ACU.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -20574.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Leases: 18552.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 245087.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 32776.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 277863.00
ACU.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -739336.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 20771.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 100160.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -331750.00
ACU.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -331750.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -331750.00
ACU.V cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -4636.00
ACU.V income_statement (quarterly, 2025-09-30) — Net Interest Income: -30658.00
ACU.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -739336.00
ACU.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -739336.00